Tech Company Financing Transactions
Elligo Health Research Funding Round
On 5/8/2019, Elligo Health Research raised $20 million in Series C investment from Piper Jaffray Ventures and private investors.
Transaction Overview
Company Name
Announced On
5/8/2019
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series C
Investors
Piper Jaffray Ventures (Lead Investor) (Thomas Schnettler)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
11612 Bee Cave Rd. Bldg. 1 150
Austin, TX 78738
USA
Austin, TX 78738
USA
Phone
Website
Email Address
Overview
We bring treatment options to patients from physicians they trust so sponsors can conduct more efficient, cost-effective trials and take products to market faster.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Potthoff
Chief Financial Officer
Karen Flaherty
Chief Information Officer
Jacylyn Dougherty
Chief Medical Officer
Faith Holmes
Chief Operating Officer
Miranda Porter
Chief Scientific Officer
Rebecca Kush
Co-Founder
Chad Moore
Vice President
Katie Eyestone
Vice President
Michael Ibara
Vice President
Vanessa Watson
VP - Administration
Eli Alford
VP - Bus. Development
Brandon Cormier
VP - Bus. Development
Keith Fern
VP - Bus. Development
Michael Gibertini
Browse more venture capital transactions:
Prev: 5/8/2019: Exabeam venture capital transaction
Next: 5/8/2019: Greyrock Energy venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs